首页> 美国卫生研究院文献>Molecular and Cellular Biology >c-Jun N-Terminal Kinase 1/c-Jun Activation of the p53/MicroRNA 34a/Sirtuin 1 Pathway Contributes to Apoptosis Induced by Deoxycholic Acid in Rat Liver
【2h】

c-Jun N-Terminal Kinase 1/c-Jun Activation of the p53/MicroRNA 34a/Sirtuin 1 Pathway Contributes to Apoptosis Induced by Deoxycholic Acid in Rat Liver

机译:c-Jun N末端激酶1 / c-Jun对p53 / MicroRNA 34a / Sirtuin 1通路的激活有助于脱氧胆酸诱导的大鼠肝细胞凋亡

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MicroRNAs (miRs) are increasingly associated with metabolic liver diseases. We have shown that ursodeoxycholic acid, a hydrophilic bile acid, counteracts the miR-34a/sirtuin 1 (SIRT1)/p53 pathway, activated in the liver of nonalcoholic steatohepatitis (NASH) patients. In contrast, hydrophobic bile acids, particularly deoxycholic acid (DCA), activate apoptosis and are increased in NASH. We evaluated whether DCA-induced apoptosis of rat hepatocytes occurs via miR-34a-dependent pathways and whether they connect with c-Jun N-terminal kinase (JNK) induction. DCA enhanced miR-34a/SIRT1/p53 proapoptotic signaling in a dose- and time-dependent manner. In turn, miR-34a inhibition and SIRT1 overexpression significantly rescued targeting of the miR-34a pathway and apoptosis by DCA. In addition, p53 overexpression activated the miR-34a/SIRT1/p53 pathway, further induced by DCA. DCA increased p53 expression as well as p53 transcriptional activation of PUMA and miR-34a itself, providing a functional mechanism for miR-34a activation. JNK1 and c-Jun were shown to be major targets of DCA, upstream of p53, in engaging the miR-34a pathway and apoptosis. Finally, activation of this JNK1/miR-34a proapoptotic circuit was also shown to occur in vivo in the rat liver. These results suggest that the JNK1/p53/miR-34a/SIRT1 pathway may represent an attractive pharmacological target for the development of new drugs to arrest metabolism- and apoptosis-related liver pathologies.
机译:微小RNA(miRs)与代谢性肝病越来越相关。我们已经显示,熊去氧胆酸,一种亲水性胆汁酸,可以抵消在非酒精性脂肪性肝炎(NASH)患者肝脏中激活的miR-34a / sirtuin 1(SIRT1)/ p53途径。相反,疏水性胆汁酸,特别是脱氧胆酸(DCA)激活细胞凋亡并在NASH中增加。我们评估了DCA诱导的大鼠肝细胞凋亡是否通过miR-34a依赖性途径发生,以及它们是否与c-Jun N端激酶(JNK)诱导相关。 DCA以剂量和时间依赖性方式增强miR-34a / SIRT1 / p53凋亡信号。反过来,miR-34a的抑制作用和SIRT1的过表达可通过DCA大大挽救miR-34a途径的靶向作用和细胞凋亡。此外,p53的过度表达激活了miR-34a / SIRT1 / p53途径,进一步被DCA诱导。 DCA增加了PUMA和miR-34a本身的p53表达以及p53转录激活,为miR-34a激活提供了功能机制。在参与miR-34a途径和凋亡时,JNK1和c-Jun被证明是p53上游DCA的主要靶标。最后,该JNK1 / miR-34a促凋亡电路的激活也显示在大鼠肝脏体内发生。这些结果表明,JNK1 / p53 / miR-34a / SIRT1途径可能代表着一种诱人的药理学靶标,可用于开发新的药物来阻止与代谢和细胞凋亡相关的肝病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号